CIK 0001553643
- Non-accelerated filer
- Smaller reporting company
RELMADA THERAPEUTICS, INC.
Sign in to watch- Ticker
- RLMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 455401931
- Phone
- +1 646-876-3459
- Business address
- 2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
- Former names
- CAMP NINE, INC.
- Open-market buys, last 90 days
- $1,671,990
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,671,990. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-27 | Shenouda Maged CFO | Sale | −1,200 | $32.43 | $39K | 2,228 |
| 2021-01-27 | Shenouda Maged CFO | Option exercise · Options to purchase common stock | −3,000 | 99,250 | ||
| 2021-01-27 | TRAVERSA SERGIO CEO | Option exercise | +10,000 | $3.24 | $32K | 85,493 |
| 2021-01-27 | TRAVERSA SERGIO CEO | Sale | −4,351 | $31.77 | $138K | 81,142 |
| 2021-01-27 | TRAVERSA SERGIO CEO | Sale | −5,549 | $32.86 | $182K | 75,593 |
| 2021-01-27 | TRAVERSA SERGIO CEO | Sale | −100 | $33.43 | $3K | 75,493 |
| 2021-01-27 | TRAVERSA SERGIO CEO | Option exercise · Options to purchase common stock | −10,000 | 148,422 | ||
| 2021-01-27 | Kelly Paul Edward Director | Option exercise | +5,000 | $3.24 | $16K | 152,295 |
| 2021-01-27 | Kelly Paul Edward Director | Sale | −1,844 | $31.69 | $58K | 150,451 |
| 2021-01-27 | Kelly Paul Edward Director | Sale | −2,988 | $32.89 | $98K | 147,463 |
| 2021-01-27 | Kelly Paul Edward Director | Sale | −168 | $33.40 | $6K | 147,295 |
| 2021-01-27 | Kelly Paul Edward Director | Option exercise · Options to purchase common stock | −5,000 | 81,415 | ||
| 2021-01-26 | Kelly Paul Edward Director | Sale | −685 | $35.16 | $24K | 147,295 |
| 2021-01-26 | TRAVERSA SERGIO CEO | Sale | −600 | $35.15 | $21K | 75,493 |
| 2021-01-26 | Shenouda Maged CFO | Sale | −607 | $35.16 | $21K | 2,228 |
| 2021-01-25 | Kelly Paul Edward Director | Sale | −1,300 | $35.27 | $46K | 147,980 |
| 2021-01-25 | TRAVERSA SERGIO CEO | Sale | −1,300 | $35.29 | $46K | 76,093 |
| 2021-01-25 | Shenouda Maged CFO | Sale | −1,280 | $35.27 | $45K | 2,835 |
| 2021-01-22 | Shenouda Maged CFO | Option exercise | +4,000 | $3.24 | $13K | 6,228 |
| 2021-01-22 | Kelly Paul Edward Director | Sale | −1,800 | $35.43 | $64K | 149,580 |
Page 12 of 19 · 370 trades